MoneyWorks4Me

Caplin Point Laboratories informs about press release

12 Jun 2023 Evaluate
Caplin Point Laboratories has informed that it has enclosed a Press Release regarding grant of United States Food and Drug Administration (USFDA) approval for the Abbreviated New Drug Application (ANDA) Cisatracurium Besylate Injection USP to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..